Mythili Koneru

2.2k total citations
29 papers, 1.7k citations indexed

About

Mythili Koneru is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Mythili Koneru has authored 29 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Immunology and 8 papers in Hematology. Recurrent topics in Mythili Koneru's work include CAR-T cell therapy research (13 papers), Multiple Myeloma Research and Treatments (8 papers) and Immune Cell Function and Interaction (8 papers). Mythili Koneru is often cited by papers focused on CAR-T cell therapy research (13 papers), Multiple Myeloma Research and Treatments (8 papers) and Immune Cell Function and Interaction (8 papers). Mythili Koneru collaborates with scholars based in United States, Netherlands and Germany. Mythili Koneru's co-authors include Renier J. Brentjens, David R. Spriggs, Terence J. Purdon, Oladapo Yeku, Roisin E. O’Cearbhaill, Alan B. Frey, David Schaer, John Glod, Sonia C. Picinich and Debabrata Banerjee and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Mythili Koneru

26 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mythili Koneru United States	13	1.3k	769	440	381	344	29	1.7k
Donald R. Shaffer United States	12	1.4k 1.1×	730 0.9×	417 0.9×	485 1.3×	377 1.1×	23	1.8k
Selene Nuñez-Cruz United States	18	1.1k 0.9×	891 1.2×	584 1.3×	365 1.0×	322 0.9×	35	1.9k
Virginia J. Hoglund United States	12	1.1k 0.8×	393 0.5×	553 1.3×	332 0.9×	345 1.0×	15	1.6k
Ignazio Caruana Italy	18	1.4k 1.1×	709 0.9×	556 1.3×	488 1.3×	496 1.4×	35	1.8k
Tiara T. Byrd United States	10	1.0k 0.8×	430 0.6×	271 0.6×	496 1.3×	315 0.9×	18	1.2k
Kevin Chow United States	11	982 0.7×	416 0.5×	270 0.6×	382 1.0×	263 0.8×	16	1.2k
Biagio De Angelis Italy	22	1.2k 0.9×	774 1.0×	543 1.2×	326 0.9×	352 1.0×	44	1.7k
Jamie R. Wagner United States	11	1.5k 1.1×	625 0.8×	410 0.9×	570 1.5×	476 1.4×	28	1.8k
Mark B. Leick United States	16	1.4k 1.1×	518 0.7×	526 1.2×	505 1.3×	408 1.2×	47	1.8k
Xin Tang China	17	674 0.5×	399 0.5×	246 0.6×	241 0.6×	208 0.6×	35	1.1k

Countries citing papers authored by Mythili Koneru

Since Specialization

Citations

This map shows the geographic impact of Mythili Koneru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mythili Koneru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mythili Koneru more than expected).

Fields of papers citing papers by Mythili Koneru

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mythili Koneru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mythili Koneru. The network helps show where Mythili Koneru may publish in the future.

Co-authorship network of co-authors of Mythili Koneru

This figure shows the co-authorship network connecting the top 25 collaborators of Mythili Koneru. A scholar is included among the top collaborators of Mythili Koneru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mythili Koneru. Mythili Koneru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dhakal, Binod, Jinghua He, Jordan M. Schecter, et al.. (2025). Real-World Treatment Patterns and Outcomes in Patients With Lenalidomide-Refractory Multiple Myeloma With 1 to 3 Prior Lines: SEER-Medicare Database. Clinical Lymphoma Myeloma & Leukemia. 25(6). e394–e403. 1 indexed citations

Voorhees, Peter M., Tom Martin, Yi Lin, et al.. (2025). Long-term (≥5 year) remission and survival after treatment with ciltacabtagene autoleucel (cilta-cel) in CARTITUDE-1 patients (pts) with relapsed/refractory multiple myeloma (RRMM).. Journal of Clinical Oncology. 43(16_suppl). 7507–7507. 1 indexed citations

Arnulf, Bertrand, Tessa Kerre, Mounzer Agha, et al.. (2024). Efficacy and safety of ciltacabtagene autoleucel ± lenalidomide maintenance in newly diagnosed multiple myeloma with suboptimal response to frontline autologous stem cell transplant: CARTITUDE-2 cohort D.. Journal of Clinical Oncology. 42(16_suppl). 7505–7505. 2 indexed citations

Costa, Luciano J., Katja Weisel, Surbhi Sidana, et al.. (2024). Ciltacabtagene autoleucel vs standard of care in patients with functional high-risk multiple myeloma: CARTITUDE-4 subgroup analysis.. Journal of Clinical Oncology. 42(16_suppl). 7504–7504. 2 indexed citations

Cohen, Adam D., Mounzer Agha, Jesús F. San Miguel, et al.. (2024). PCR134 Psychometric Properties of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in Patients with Relapsed/Refractory Multiple Myeloma (MM): Analysis of Phase 2 CARTITUDE-2 Study Cohorts A, B, and C. Value in Health. 27(6). S320–S320.

Costa, Luciano J., Katja Weisel, Surbhi Sidana, et al.. (2024). MM-549 Ciltacabtagene Autoleucel vs Standard of Care in Patients With Functional High-Risk Multiple Myeloma: CARTITUDE-4 Subgroup Analysis. Clinical Lymphoma Myeloma & Leukemia. 24. S569–S570.

Tonetti, Daniel A., Mythili Koneru, Eytan Raz, et al.. (2024). LB-011 Aristotle colossus guidewire in acute anterior circulation ischemic stroke thrombectomy: a multicenter experience. A274–A275. 1 indexed citations

Yeku, Oladapo, Sarwish Rafiq, Mythili Koneru, et al.. (2020). Abstract IA21: MUC16-directed immunotherapy for ovarian cancer. Clinical Cancer Research. 26(13_Supplement). IA21–IA21. 2 indexed citations

O’Hara, Mark H., Wells A. Messersmith, Hedy L. Kindler, et al.. (2020). Safety and Pharmacokinetics of CXCR4 Peptide Antagonist, LY2510924, in Combination with Durvalumab in Advanced Refractory Solid Tumors. SHILAP Revista de lepidopterología. 6(1). 21–31. 37 indexed citations

10.

Harding, James J., Amita Patnaik, Víctor Moreno, et al.. (2019). A phase Ia/Ib study of an anti-TIM-3 antibody (LY3321367) monotherapy or in combination with an anti-PD-L1 antibody (LY3300054): Interim safety, efficacy, and pharmacokinetic findings in advanced cancers.. Journal of Clinical Oncology. 37(8_suppl). 12–12. 65 indexed citations

11.

Rafiq, Sarwish, Terence J. Purdon, Anthony F. Daniyan, et al.. (2016). Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen. Leukemia. 31(8). 1788–1797. 128 indexed citations

12.

Koneru, Mythili, et al.. (2015). A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16ecto directed chimeric antigen receptors for recurrent ovarian cancer. Journal of Translational Medicine. 13(1). 102–102. 225 indexed citations

13.

Koneru, Mythili, et al.. (2015). IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors in vivo. OncoImmunology. 4(3). e994446–e994446. 361 indexed citations

14.

Koneru, Mythili & Richard D. Carvajal. (2012). A new era for the management of metastatic melanoma. Expert Review of Dermatology. 7(1). 27–35. 1 indexed citations

15.

Lin, Sze‐Kwan, H. J. Yang, Allen D. Everett, et al.. (2008). The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells. Experimental Cell Research. 314(17). 3107–3117. 46 indexed citations

16.

Koneru, Mythili, Ngozi Monu, David Schaer, Justine A. Barletta, & Alan B. Frey. (2006). Defective Adhesion in Tumor Infiltrating CD8+ T Cells. The Journal of Immunology. 176(10). 6103–6111. 28 indexed citations

17.

Menon, Lata G., Sonia C. Picinich, Rajeth Koneru, et al.. (2006). Differential Gene Expression Associated with Migration of Mesenchymal Stem Cells to Conditioned Medium from Tumor Cells or Bone Marrow Cells. Stem Cells. 25(2). 520–528. 199 indexed citations

18.

Simmons, William J., Mythili Koneru, Mani Mohindru, et al.. (2005). Tim-3+ T-bet+ Tumor-Specific Th1 Cells Colocalize with and Inhibit Development and Growth of Murine Neoplasms. The Journal of Immunology. 174(3). 1405–1415. 25 indexed citations

19.

Koneru, Mythili, et al.. (2005). Defective Proximal TCR Signaling Inhibits CD8+ Tumor-Infiltrating Lymphocyte Lytic Function. The Journal of Immunology. 174(4). 1830–1840. 61 indexed citations

20.

Radoja, Saša, Masanao Saio, David Schaer, et al.. (2001). CD8+ Tumor-Infiltrating T Cells Are Deficient in Perforin-Mediated Cytolytic Activity Due to Defective Microtubule-Organizing Center Mobilization and Lytic Granule Exocytosis. The Journal of Immunology. 167(9). 5042–5051. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact